Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2019 | Story Zama Feni | Photo Zama Feni
CrazySocksForDocs
UFS medical students displaying multi-coloured mismatched socks as they heeded the call of the #CrazySocks4Doc campaign to raise awareness about mental health in the medical profession.

Hundreds of pairs of socks were dished out to medical students last week during the campus launch of the #CrazySocks4Docs (#CS4D) awareness campaign that seeks to help break the silence around mental-health illness in the medical profession.
 
More than 600 medical students from the University of the Free State (UFS) School of Internal Medicine heeded the call by the non-governmental organisation, Ithemba Foundation, whose mission is to educate the public around mental health – specifically depression and related diseases such as anxiety disorders – and to support research.

On Monday, 3 June 2019, the Ithemba Foundation launched the CS4D campaign countrywide at all tertiary institutions with medical schools to help break the silence around mental health in the medical profession. 

“We have ensured a sponsorship of 10 000 pairs of mismatched socks for medical students, to be distributed according to student numbers at each medical campus,” Ithemba Foundation said in a statement.

Students waking up to the call

A large number of UFS medical students gladly embraced the call and helped themselves to pairs of multi-coloured socks at the James Moroka Building foyer on the Bloemfontein Campus.

Judy Modise, a second-year medical student, said she was impressed with the initiative.
“I think this is a very interesting campaign, as we all know the devastating effects of mental health in society, and more specifically on doctors,” she said.

UFS has risen to the challenge

In a widely published opinion piece on mental health in October last year, UFS Rector and Vice-Chancellor Prof Francis Petersen, stated that one in every three South Africans suffers from some form of mental disorder.

He mentioned that, “The university has just released a first draft of its first-ever Student Mental Health Policy.”

“This policy seeks to redress the inequalities and disadvantages created by prejudice and discrimination against persons with mental-health disabilities and difficulties,” said Prof Petersen.
 
Destigmatising mental health is key

The Ithemba Foundation further stated that, “It is critical that we start the conversation around mental health in the health profession – especially among the next generation of medical professionals, as the stigma surrounding the illness in doctors persists. Wearing mismatched, brightly-coloured socks may seem like a weird place to begin, but to care for others, we also have to care for ourselves and each other.”

The purpose of the campaign is to create awareness about the highly stressful nature of the medical profession; the need for doctors to seek help when needed, both mental and physical; the need for those in the health profession to help one another and the need to reshape the culture of the health care industry and to ensure that you will have a new mindset concerning your own mental health. 


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept